Quarterly report (Form 10-Q)
Bristol Myers Squibb 10-Q for Quarter ended Mar 31, 2026
Filing excerpt
Additionally, revenues were impacted by lower average net selling prices for the Legacy Portfolio. Average U.S. net selling prices decreased 1% compared to the corresponding period a year ago.